Active Ingredient History
Vonoprazan, sold under the brand name Voquezna among others, is a first-in-class potassium-competitive acid blocker medication. Vonoprazan is used in form of the fumarate for the treatment of gastroduodenal ulcer and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori. It is a potassium-competitive acid blocker. Wikipedia
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Helicobacter Infections (approved 2022)
Acute Coronary Syndrome (Phase 4)
Drugs, Investigational (Phase 1)
Drug Therapy (Phase 4)
Duodenal Ulcer (Phase 3)
Esophageal and Gastric Varices (Phase 3)
Esophagitis (Phase 4)
Esophagitis, Peptic (Phase 4)
Fasting (Phase 1)
Gastritis (Phase 4)
Gastroesophageal Reflux (Phase 4)
Healthy Volunteers (Phase 3)
Heartburn (Phase 2)
Helicobacter pylori (Phase 4)
Hypertension, Portal (Phase 3)
Intestinal Neoplasms (Phase 2)
Peptic Ulcer (Phase 3)
Proton Pump Inhibitors (Phase 4)
Stomach Ulcer (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue